http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 01 Jul 2026 21:07:42 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html <p>GNI Group Ltd. (TSE: 2160) announced it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone, making Ayumi Pharmaceutical Holdings and its subsidiary, Ayumi Pharmaceutical Co., Ltd., wholly owned subsidiaries of GNI Group.</p> <p>The transaction was settled at an enterprise value of approximately ¥44.8 billion, funded through a combination of cash and the issuance of new GNI Group shares. As part of the deal, Blackstone, Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. have become new shareholders of GNI Group.</p> <p>Ayumi Pharmaceutical recorded revenue of approximately ¥38.5 billion for the fiscal year http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html Wed, 01 Jul 2026 21:07:42 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html <p>GNI Group Ltd. (TSE: 2160) announced it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone, making Ayumi Pharmaceutical Holdings and its subsidiary, Ayumi Pharmaceutical Co., Ltd., wholly owned subsidiaries of GNI Group.</p> <p>The transaction was settled at an enterprise value of approximately ¥44.8 billion, funded through a combination of cash and the issuance of new GNI Group shares. As part of the deal, Blackstone, Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. have become new shareholders of GNI Group.</p> <p>Ayumi Pharmaceutical recorded revenue of approximately ¥38.5 billion for the fiscal year http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html Wed, 01 Jul 2026 21:07:42 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html <p>GNI Group Ltd. (TSE: 2160) announced it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone, making Ayumi Pharmaceutical Holdings and its subsidiary, Ayumi Pharmaceutical Co., Ltd., wholly owned subsidiaries of GNI Group.</p> <p>The transaction was settled at an enterprise value of approximately ¥44.8 billion, funded through a combination of cash and the issuance of new GNI Group shares. As part of the deal, Blackstone, Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. have become new shareholders of GNI Group.</p> <p>Ayumi Pharmaceutical recorded revenue of approximately ¥38.5 billion for the fiscal year http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html Wed, 01 Jul 2026 21:07:42 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html <p>GNI Group Ltd. (TSE: 2160) announced it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone, making Ayumi Pharmaceutical Holdings and its subsidiary, Ayumi Pharmaceutical Co., Ltd., wholly owned subsidiaries of GNI Group.</p> <p>The transaction was settled at an enterprise value of approximately ¥44.8 billion, funded through a combination of cash and the issuance of new GNI Group shares. As part of the deal, Blackstone, Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. have become new shareholders of GNI Group.</p> <p>Ayumi Pharmaceutical recorded revenue of approximately ¥38.5 billion for the fiscal year http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html Wed, 01 Jul 2026 21:07:42 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html <p>GNI Group Ltd. (TSE: 2160) announced it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone, making Ayumi Pharmaceutical Holdings and its subsidiary, Ayumi Pharmaceutical Co., Ltd., wholly owned subsidiaries of GNI Group.</p> <p>The transaction was settled at an enterprise value of approximately ¥44.8 billion, funded through a combination of cash and the issuance of new GNI Group shares. As part of the deal, Blackstone, Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. have become new shareholders of GNI Group.</p> <p>Ayumi Pharmaceutical recorded revenue of approximately ¥38.5 billion for the fiscal year http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html Wed, 01 Jul 2026 21:07:42 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html <p>GNI Group Ltd. (TSE: 2160) announced it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone, making Ayumi Pharmaceutical Holdings and its subsidiary, Ayumi Pharmaceutical Co., Ltd., wholly owned subsidiaries of GNI Group.</p> <p>The transaction was settled at an enterprise value of approximately ¥44.8 billion, funded through a combination of cash and the issuance of new GNI Group shares. As part of the deal, Blackstone, Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. have become new shareholders of GNI Group.</p> <p>Ayumi Pharmaceutical recorded revenue of approximately ¥38.5 billion for the fiscal year http://www.streetinsider.com/Mergers+and+Acquisitions/GNI+Group+acquires+Ayumi+Pharmaceutical+for+%C2%A544.8+billion/26722762.html Wed, 01 Jul 2026 21:07:42 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Press+Releases/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html <p align="left">TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has completed the acquisition of all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. As a result, Ayumi Pharmaceutical Holdings Co., Ltd. and its subsidiary, Ayumi Pharmaceutical Co., Ltd. (“Ayumi Pharmaceutical”), have become wholly owned subsidiaries of the Company.</p> <p align="left">Since its founding in 2001 and listing in 2007, GNI Group has pursued global growth as a Japan-originated company, while expanding its business operations in China, the United States and Australia. http://www.streetinsider.com/Globe+Newswire/GNI+Group+Completes+Acquisition+of+AYUMI+Pharmaceutical/26722761.html Wed, 01 Jul 2026 21:07:00 -0400 2160 A.42678759 HTSUY O.05105679 O.05105942 O.41030728 http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html <p>TOKYO, Feb 24, 2026 - (JCN Newswire) - - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three men and women finishers of the marathon and wheelchair marathon events at the Tokyo Marathon 2026. The Tokyo Marathon 2026 is organized by the Tokyo Marathon Foundation and will be held on March 1, 2026.</p><p>Design Representing All the Participants in the Event with Woven Lines</p><p>The medals were designed based on the concept of the Tokyo Marathon: The Day We Unite. On the front http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html Tue, 24 Feb 2026 07:00:00 -0400 2702 4530 6849 8411 A.00727556 A.04452092 A.09257921 A.10571236 A.14585554 A.17904968 A.19483282 A.21797943 A.25529364 A.27009962 A.28974129 A.29331106 A.41195265 A.42243014 A.50213574 HPX HTSUF HTSUY M4I MA MFG MZ8A NHNKF NHNKY O.00188937 O.00189087 O.00189315 O.00496151 O.00729045 O.01273079 O.04957665 O.05105679 O.05105727 O.05105762 O.05335073 O.05372727 O.05375760 O.05475475 O.05611598 O.15247644 O.26300725 O.49044617 http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html <p>TOKYO, Feb 24, 2026 - (JCN Newswire) - - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three men and women finishers of the marathon and wheelchair marathon events at the Tokyo Marathon 2026. The Tokyo Marathon 2026 is organized by the Tokyo Marathon Foundation and will be held on March 1, 2026.</p><p>Design Representing All the Participants in the Event with Woven Lines</p><p>The medals were designed based on the concept of the Tokyo Marathon: The Day We Unite. On the front http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html Tue, 24 Feb 2026 07:00:00 -0400 2702 4530 6849 8411 A.00727556 A.04452092 A.09257921 A.10571236 A.14585554 A.17904968 A.19483282 A.21797943 A.25529364 A.27009962 A.28974129 A.29331106 A.41195265 A.42243014 A.50213574 HPX HTSUF HTSUY M4I MA MFG MZ8A NHNKF NHNKY O.00188937 O.00189087 O.00189315 O.00496151 O.00729045 O.01273079 O.04957665 O.05105679 O.05105727 O.05105762 O.05335073 O.05372727 O.05375760 O.05475475 O.05611598 O.15247644 O.26300725 O.49044617 http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html <p>TOKYO, Feb 24, 2026 - (JCN Newswire) - - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three men and women finishers of the marathon and wheelchair marathon events at the Tokyo Marathon 2026. The Tokyo Marathon 2026 is organized by the Tokyo Marathon Foundation and will be held on March 1, 2026.</p><p>Design Representing All the Participants in the Event with Woven Lines</p><p>The medals were designed based on the concept of the Tokyo Marathon: The Day We Unite. On the front http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html Tue, 24 Feb 2026 07:00:00 -0400 2702 4530 6849 8411 A.00727556 A.04452092 A.09257921 A.10571236 A.14585554 A.17904968 A.19483282 A.21797943 A.25529364 A.27009962 A.28974129 A.29331106 A.41195265 A.42243014 A.50213574 HPX HTSUF HTSUY M4I MA MFG MZ8A NHNKF NHNKY O.00188937 O.00189087 O.00189315 O.00496151 O.00729045 O.01273079 O.04957665 O.05105679 O.05105727 O.05105762 O.05335073 O.05372727 O.05375760 O.05475475 O.05611598 O.15247644 O.26300725 O.49044617 http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html <p>TOKYO, Feb 24, 2026 - (JCN Newswire) - - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three men and women finishers of the marathon and wheelchair marathon events at the Tokyo Marathon 2026. The Tokyo Marathon 2026 is organized by the Tokyo Marathon Foundation and will be held on March 1, 2026.</p><p>Design Representing All the Participants in the Event with Woven Lines</p><p>The medals were designed based on the concept of the Tokyo Marathon: The Day We Unite. On the front http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html Tue, 24 Feb 2026 07:00:00 -0400 2702 4530 6849 8411 A.00727556 A.04452092 A.09257921 A.10571236 A.14585554 A.17904968 A.19483282 A.21797943 A.25529364 A.27009962 A.28974129 A.29331106 A.41195265 A.42243014 A.50213574 HPX HTSUF HTSUY M4I MA MFG MZ8A NHNKF NHNKY O.00188937 O.00189087 O.00189315 O.00496151 O.00729045 O.01273079 O.04957665 O.05105679 O.05105727 O.05105762 O.05335073 O.05372727 O.05375760 O.05475475 O.05611598 O.15247644 O.26300725 O.49044617 http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html <p>TOKYO, Feb 24, 2026 - (JCN Newswire) - - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three men and women finishers of the marathon and wheelchair marathon events at the Tokyo Marathon 2026. The Tokyo Marathon 2026 is organized by the Tokyo Marathon Foundation and will be held on March 1, 2026.</p><p>Design Representing All the Participants in the Event with Woven Lines</p><p>The medals were designed based on the concept of the Tokyo Marathon: The Day We Unite. On the front http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html Tue, 24 Feb 2026 07:00:00 -0400 2702 4530 6849 8411 A.00727556 A.04452092 A.09257921 A.10571236 A.14585554 A.17904968 A.19483282 A.21797943 A.25529364 A.27009962 A.28974129 A.29331106 A.41195265 A.42243014 A.50213574 HPX HTSUF HTSUY M4I MA MFG MZ8A NHNKF NHNKY O.00188937 O.00189087 O.00189315 O.00496151 O.00729045 O.01273079 O.04957665 O.05105679 O.05105727 O.05105762 O.05335073 O.05372727 O.05375760 O.05475475 O.05611598 O.15247644 O.26300725 O.49044617 http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html <p>TOKYO, Feb 24, 2026 - (JCN Newswire) - - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three men and women finishers of the marathon and wheelchair marathon events at the Tokyo Marathon 2026. The Tokyo Marathon 2026 is organized by the Tokyo Marathon Foundation and will be held on March 1, 2026.</p><p>Design Representing All the Participants in the Event with Woven Lines</p><p>The medals were designed based on the concept of the Tokyo Marathon: The Day We Unite. On the front http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html Tue, 24 Feb 2026 07:00:00 -0400 2702 4530 6849 8411 A.00727556 A.04452092 A.09257921 A.10571236 A.14585554 A.17904968 A.19483282 A.21797943 A.25529364 A.27009962 A.28974129 A.29331106 A.41195265 A.42243014 A.50213574 HPX HTSUF HTSUY M4I MA MFG MZ8A NHNKF NHNKY O.00188937 O.00189087 O.00189315 O.00496151 O.00729045 O.01273079 O.04957665 O.05105679 O.05105727 O.05105762 O.05335073 O.05372727 O.05375760 O.05475475 O.05611598 O.15247644 O.26300725 O.49044617 http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html <p>TOKYO, Feb 24, 2026 - (JCN Newswire) - - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) will provide and donate gold, silver, and bronze medals to the top three men and women finishers of the marathon and wheelchair marathon events at the Tokyo Marathon 2026. The Tokyo Marathon 2026 is organized by the Tokyo Marathon Foundation and will be held on March 1, 2026.</p><p>Design Representing All the Participants in the Event with Woven Lines</p><p>The medals were designed based on the concept of the Tokyo Marathon: The Day We Unite. On the front http://www.streetinsider.com/Press+Releases/TANAKA+to+Provide+Medals+for+the+Tokyo+Marathon+2026+That+Represent+All+the+Participants+in+the+Event+with+Woven+Lines/26048292.html Tue, 24 Feb 2026 07:00:00 -0400 2702 4530 6849 8411 A.00727556 A.04452092 A.09257921 A.10571236 A.14585554 A.17904968 A.19483282 A.21797943 A.25529364 A.27009962 A.28974129 A.29331106 A.41195265 A.42243014 A.50213574 HPX HTSUF HTSUY M4I MA MFG MZ8A NHNKF NHNKY O.00188937 O.00189087 O.00189315 O.00496151 O.00729045 O.01273079 O.04957665 O.05105679 O.05105727 O.05105762 O.05335073 O.05372727 O.05375760 O.05475475 O.05611598 O.15247644 O.26300725 O.49044617